Pekka Kallunki,Karina Fog,Louise Buur Vesterager,Ann-Louise Bergstrôm,Florence Sotty,David Satijn,Edward van den Brink,Paul Parren,Rik Rademaker,Tom Vink,Ibrahim John Malik,Liliana Christina Pereira M
申请号：
US15812251
公开号：
US10358482B2
申请日:
2017.11.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
